289 related articles for article (PubMed ID: 24028839)
1. Fas/FasL pathway participates in resolution of mucosal inflammatory response early during HSV-2 infection.
Krzyzowska M; Baska P; Grochowska A; Orlowski P; Nowak Z; Winnicka A
Immunobiology; 2014 Jan; 219(1):64-77. PubMed ID: 24028839
[TBL] [Abstract][Full Text] [Related]
2. HSV-2 regulates monocyte inflammatory response via the Fas/FasL pathway.
Krzyzowska M; Baska P; Orlowski P; Zdanowski R; Winnicka A; Eriksson K; Stankiewicz W
PLoS One; 2013; 8(7):e70308. PubMed ID: 23922974
[TBL] [Abstract][Full Text] [Related]
3. Role of Fas/FasL signaling in regulation of anti-viral response during HSV-2 vaginal infection in mice.
Krzyzowska M; Orłowski P; Bąska P; Bodera P; Zdanowski R; Stankiewicz W
Immunobiology; 2014 Dec; 219(12):932-43. PubMed ID: 25129477
[TBL] [Abstract][Full Text] [Related]
4. Role of Fas/FasL in regulation of inflammation in vaginal tissue during HSV-2 infection.
Krzyzowska M; Shestakov A; Eriksson K; Chiodi F
Cell Death Dis; 2011 Mar; 2(3):e132. PubMed ID: 21412278
[TBL] [Abstract][Full Text] [Related]
5. T-cell-mediated mechanisms involved in resolution of genital herpes simplex virus type 2 (HSV-2) infection of mice.
Milligan GN; Dudley-McClain KL; Young CG; Chu CF
J Reprod Immunol; 2004 Apr; 61(2):115-27. PubMed ID: 15063634
[TBL] [Abstract][Full Text] [Related]
6. Herpes simplex virus type 2 infection induced apoptosis in peritoneal macrophages independent of Fas and tumor necrosis factor-receptor signaling.
Fleck M; Mountz JD; Hsu HC; Wu J; Edwards CK; Kern ER
Viral Immunol; 1999; 12(3):263-75. PubMed ID: 10532654
[TBL] [Abstract][Full Text] [Related]
7. A lack of Fas/FasL signalling leads to disturbances in the antiviral response during ectromelia virus infection.
Bień K; Sobańska Z; Sokołowska J; Bąska P; Nowak Z; Winnicka A; Krzyzowska M
Arch Virol; 2016 Apr; 161(4):913-28. PubMed ID: 26780774
[TBL] [Abstract][Full Text] [Related]
8. A sustained type I IFN-neutrophil-IL-18 axis drives pathology during mucosal viral infection.
Lebratti T; Lim YS; Cofie A; Andhey P; Jiang X; Scott J; Fabbrizi MR; Ozantürk AN; Pham C; Clemens R; Artyomov M; Dinauer M; Shin H
Elife; 2021 May; 10():. PubMed ID: 34047696
[TBL] [Abstract][Full Text] [Related]
9. Fas/FasL pathway participates in regulation of antiviral and inflammatory response during mousepox infection of lungs.
Bień K; Sokołowska J; Bąska P; Nowak Z; Stankiewicz W; Krzyzowska M
Mediators Inflamm; 2015; 2015():281613. PubMed ID: 25873756
[TBL] [Abstract][Full Text] [Related]
10. Macrophage-inducing FasL on chondrocytes forms immune privilege in cartilage tissue engineering, enhancing in vivo regeneration.
Fujihara Y; Takato T; Hoshi K
Stem Cells; 2014 May; 32(5):1208-19. PubMed ID: 24446149
[TBL] [Abstract][Full Text] [Related]
11. The ribonucleotide reductase R1 subunits of herpes simplex virus types 1 and 2 protect cells against TNFα- and FasL-induced apoptosis by interacting with caspase-8.
Dufour F; Sasseville AM; Chabaud S; Massie B; Siegel RM; Langelier Y
Apoptosis; 2011 Mar; 16(3):256-71. PubMed ID: 21107701
[TBL] [Abstract][Full Text] [Related]
12. Inducible nitric oxide synthase and Fas/FasL with C3 expression of mouse retinal pigment epithelial cells in response to stimulation by peroxynitrite and antagonism of puerarin.
Hao LN; Zhang YQ; Shen YH; Wang ZY; Wang YH
Chin Med J (Engl); 2011 Aug; 124(16):2522-9. PubMed ID: 21933599
[TBL] [Abstract][Full Text] [Related]
13. Protective role of Fas-FasL signaling in lethal infection with herpes simplex virus type 2 in mice.
Ishikawa T; Yamada H; Oyamada A; Goshima F; Nishiyama Y; Yoshikai Y
J Virol; 2009 Nov; 83(22):11777-83. PubMed ID: 19740996
[TBL] [Abstract][Full Text] [Related]
14. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.
Parr MB; Kepple L; McDermott MR; Drew MD; Bozzola JJ; Parr EL
Lab Invest; 1994 Mar; 70(3):369-80. PubMed ID: 8145530
[TBL] [Abstract][Full Text] [Related]
15. Clearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin- or Fas-mediated cytolytic mechanisms.
Dobbs ME; Strasser JE; Chu CF; Chalk C; Milligan GN
J Virol; 2005 Dec; 79(23):14546-54. PubMed ID: 16282454
[TBL] [Abstract][Full Text] [Related]
16. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
Gill N; Rosenthal KL; Ashkar AA
J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
[TBL] [Abstract][Full Text] [Related]
17. IL-36γ Is a Key Regulator of Neutrophil Infiltration in the Vaginal Microenvironment and Limits Neuroinvasion in Genital HSV-2 Infection.
Gardner JK; Swaims-Kohlmeier A; Herbst-Kralovetz MM
J Immunol; 2019 Nov; 203(10):2655-2664. PubMed ID: 31578266
[TBL] [Abstract][Full Text] [Related]
18. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
[TBL] [Abstract][Full Text] [Related]
19. Roles of Fas and Fas ligand during mammary gland remodeling.
Song J; Sapi E; Brown W; Nilsen J; Tartaro K; Kacinski BM; Craft J; Naftolin F; Mor G
J Clin Invest; 2000 Nov; 106(10):1209-20. PubMed ID: 11086022
[TBL] [Abstract][Full Text] [Related]
20. A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer.
Hall SJ; Canfield SE; Yan Y; Hassen W; Selleck WA; Chen SH
Gene Ther; 2002 Apr; 9(8):511-7. PubMed ID: 11948376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
